Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Likely To Leave Harder Decisions On COVID-19 Boosters To CDC
Sep 15 2021
•
By
Sarah Karlin-Smith
FDA may punt the more controversial COVID-19 booster decisions to CDC • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Vaccines
More from Pink Sheet